132 related articles for article (PubMed ID: 17216123)
1. Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure?
Schietinger BJ; Voros S; Isbell DC; Meyer CH; Christopher JM; Kramer CM
Int J Cardiovasc Imaging; 2007 Oct; 23(5):595-602. PubMed ID: 17216123
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction.
Di Bella G; Pingitore A; Piaggi P; Pizzino F; Barison A; Terrizzi A; d'angelo M; Todiere G; Quattrocchi S; Carerj S; Emdin M; Aquaro GD
Int J Cardiol; 2016 Dec; 224():337-342. PubMed ID: 27668708
[TBL] [Abstract][Full Text] [Related]
4. Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure.
Valle-Muñoz A; Estornell-Erill J; Soriano-Navarro CJ; Nadal-Barange M; Martinez-Alzamora N; Pomar-Domingo F; Corbí-Pascual M; Payá-Serrano R; Ridocci-Soriano F
Eur J Echocardiogr; 2009 Dec; 10(8):968-74. PubMed ID: 19755468
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.
Manchuelle A; Pontana F; De Groote P; Lebert P; Fertin M; Baijot M; Hurt C; Lamblin N; Debry N; Schurtz G; Pentiah AD; Sudre A; Remy-Jardin M; Lancellotti P; Van Belle E; Bauters C; Lemesle G; Delhaye C
Arch Cardiovasc Dis; 2018 Nov; 111(11):686-701. PubMed ID: 29861294
[TBL] [Abstract][Full Text] [Related]
6. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement.
Casolo G; Minneci S; Manta R; Sulla A; Del Meglio J; Rega L; Gensini G
Am Heart J; 2006 Jan; 151(1):101-8. PubMed ID: 16368300
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement.
Barone-Rochette G; Piérard S; De Meester de Ravenstein C; Seldrum S; Melchior J; Maes F; Pouleur AC; Vancraeynest D; Pasquet A; Vanoverschelde JL; Gerber BL
J Am Coll Cardiol; 2014 Jul; 64(2):144-54. PubMed ID: 25011718
[TBL] [Abstract][Full Text] [Related]
8. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
[TBL] [Abstract][Full Text] [Related]
10. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol.
Bernhardt P; Spiess J; Levenson B; Pilz G; Höfling B; Hombach V; Strohm O
JACC Cardiovasc Imaging; 2009 Nov; 2(11):1292-300. PubMed ID: 19909933
[TBL] [Abstract][Full Text] [Related]
11. Additive value of magnetic resonance coronary angiography in a comprehensive cardiac magnetic resonance stress-rest protocol for detection of functionally significant coronary artery disease: a pilot study.
Bettencourt N; Ferreira N; Chiribiri A; Schuster A; Sampaio F; Santos L; Melica B; Rodrigues A; Braga P; Teixeira M; Leite-Moreira A; Silva-Cardoso J; Portugal P; Gama V; Nagel E
Circ Cardiovasc Imaging; 2013 Sep; 6(5):730-8. PubMed ID: 23833284
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients.
Pedrotti P; Vittori C; Facchetti R; Pedretti S; Dellegrottaglie S; Milazzo A; Frigerio M; Cipriani M; Giannattasio C; Roghi A; Rimoldi O
Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):130-137. PubMed ID: 27625368
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Evaluation of Newly Diagnosed Heart Failure With Reduced Left Ventricular Ejection Fraction.
Won E; Donnino R; Srichai MB; Sedlis SP; Feit F; Rolnitzky L; Miller LH; Iqbal SN; Axel L; Nguyen B; Slater J; Shah B
Am J Cardiol; 2015 Oct; 116(7):1082-7. PubMed ID: 26251006
[TBL] [Abstract][Full Text] [Related]
14. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience.
Soriano CJ; Ridocci F; Estornell J; Pérez-Boscá JL; Pomar F; Trigo A; Planas A; Nadal M; Jacas V; Martinez V; Paya R
Int J Cardiol; 2007 Mar; 116(2):167-73. PubMed ID: 16828180
[TBL] [Abstract][Full Text] [Related]
15. Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women.
Klem I; Greulich S; Heitner JF; Kim H; Vogelsberg H; Kispert EM; Ambati SR; Bruch C; Parker M; Judd RM; Kim RJ; Sechtem U
JACC Cardiovasc Imaging; 2008 Jul; 1(4):436-45. PubMed ID: 19356464
[TBL] [Abstract][Full Text] [Related]
16. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
[TBL] [Abstract][Full Text] [Related]
17. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
[TBL] [Abstract][Full Text] [Related]
18. Dobutamine stress cardiovascular magnetic resonance at 3 Tesla.
Kelle S; Hamdan A; Schnackenburg B; Köhler U; Klein C; Nagel E; Fleck E
J Cardiovasc Magn Reson; 2008 Oct; 10(1):44. PubMed ID: 18844984
[TBL] [Abstract][Full Text] [Related]
19. Validating an Idiopathic Dilated Cardiomyopathy Diagnosis Using Cardiovascular Magnetic Resonance: The Dilated Cardiomyopathy Precision Medicine Study.
Haas GJ; Zareba KM; Ni H; Bello-Pardo E; Huggins GS; Hershberger RE;
Circ Heart Fail; 2022 May; 15(5):e008877. PubMed ID: 35240856
[TBL] [Abstract][Full Text] [Related]
20. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
